GNPAT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.351200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.995600E-01
Normal-vs-Stage2
2.913400E-01
Normal-vs-Stage3
3.946400E-01
Normal-vs-Stage4
4.931800E-02
Stage1-vs-Stage2
7.957800E-01
Stage1-vs-Stage3
1.566040E-01
Stage1-vs-Stage4
4.885800E-01
Stage2-vs-Stage3
3.620400E-02
Stage2-vs-Stage4
1.953780E-01
Stage3-vs-Stage4
2.273700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.936400E-01
Normal-vs-AfricanAmerican
3.917600E-02
Normal-vs-Asian
1.493420E-01
Caucasian-vs-AfricanAmerican
5.251900E-02
Caucasian-vs-Asian
2.268000E-01
AfricanAmerican-vs-Asian
3.672200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.193200E-01
Normal-vs-Female
3.746800E-01
Male-vs-Female
3.461000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.325200E-01
Normal-vs-Age(41-60Yrs)
2.582200E-01
Normal-vs-Age(61-80Yrs)
3.753400E-01
Normal-vs-Age(81-100Yrs)
3.187000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.279000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.373800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.101000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.726800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.855400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.277800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.089600E-01
Normal-vs-Daily Drinker
8.895000E-01
Normal-vs-Weekly Drinker
2.659000E-01
Normal-vs-Occasional Drinker
1.398200E-01
Normal-vs-Social Drinker
1.278800E-01
Non Drinker-vs-Daily Drinker
2.002000E-01
Non Drinker-vs-Weekly Drinker
3.401000E-01
Non Drinker-vs-Occasional Drinker
2.810400E-01
Non Drinker-vs-Social Drinker
4.644200E-01
Daily Drinker-vs-Weekly Drinker
7.964200E-02
Daily Drinker-vs-Occasional Drinker
4.043900E-02
Daily Drinker-vs-Social Drinker
8.193700E-02
Weekly Drinker-vs-Occasional Drinker
9.515600E-01
Weekly Drinker-vs-Social Drinker
7.481400E-01
Occasional Drinker-vs-Social Drinker
7.376600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.876100E-02
Normal-vs-Grade 2
3.435200E-03
Normal-vs-Grade 3
4.922800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.082010E-01
Grade 1-vs-Grade 3
1.613640E-01
Grade 1-vs-Grade 4
5.876100E-02
Grade 2-vs-Grade 3
9.752800E-01
Grade 2-vs-Grade 4
3.435200E-03
Grade 3-vs-Grade 4
4.922800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.668800E-01
Normal-vs-NonDiabetic
2.726400E-01
Diabetic-vs-NonDiabetic
4.740400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.318640E-01
Normal-vs-NoPancreatitis
3.879400E-01
Pancreatitis-vs-NoPancreatitis
6.883800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.604200E-01
Normal-vs-N1
3.378800E-01
N0-vs-N1
2.268600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.231600E-02
Normal-vs-TP53-NonMutant
3.220400E-01
TP53-Mutant-vs-TP53-NonMutant
4.516000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
